Inflammation, excacerbation of heart failure, and ventricular tachyarrhythmias in stable heart failure patients with implantable cardioverter-defibrillator.

Recruiting

• Conditions: Sudden cardiac death; ventricular arrhythmias; 10007521

• Registration Number: NL-OMON30360
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Patients with a ClassI/Class II indication for ICD therapy
Patient with NYHA Class II and higher

Exclusion Criteria

Replacement of a pulsegenerator
Permanent atrial fibrillation
Life expectancy < 1 year

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The association between ventricular arrhythmias and biomarkers (hs-CRP and<br /><br>BNP).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>